LAWRENCE, Mass., March 19, 2015 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of
dialysis products, is proud to celebrate the second annual Home
Hemodialysis Day today, March 19,
2015, during National Kidney Month. Observed annually on the
third Thursday of March, this initiative is dedicated to raising
awareness of home hemodialysis, including nocturnal therapy, with
the NxStage® System One™ and empowering dialysis patients to choose
a therapy that is right for them. This evening in Boston, the city's iconic Zakim Bridge will be
lit green in support of NxStage's awareness efforts and to
commemorate Home Hemodialysis Day.
Home Hemodialysis Day provides a platform for home dialyzors and
their care partners to share their experiences and stories with
others to strengthen the home hemodialysis community. To
celebrate the day, NxStage is distributing green ribbons at
dialysis centers across the country and highlighting inspiring
patient stories at
http://ww2.nxstage.com/patient-stories.html. At the same
time, the Company is encouraging patients and care partners to
unite, spread the word and capture their support using the hashtag,
#HomeHemodialysisDay.
"With home nocturnal therapy, I get to live life on my own
terms," said Robby Richardson of
Savannah, GA who performs more
frequent nocturnal therapy at home with the System One. "By doing
my treatments while I sleep, I feel better and am able to maintain
my full-time job teaching special education to high school
students. Nocturnal therapy has worked so well for me that I've
also gone back to my passion of leading ghost tours around the
historic district in Savannah.
Nocturnal therapy has allowed me to make dialysis work for my life,
and not the other way around."
"We have made huge strides in advancing access to home
hemodialysis care over the years, most recently receiving FDA
clearance for the System One as the first and only machine approved
for nocturnal therapy," said NxStage President, Joe Turk. "Still, only a tiny fraction of
patients that could truly benefit have access today. We are
building on the tradition of National Home Hemodialysis Day to
empower all of our patients to share their life-changing stories,
and help others understand the significant clinical and quality of
life benefits that our home hemodialysis therapies can offer."
For more information about the System One, or home nocturnal
hemodialysis, please visit www.nxstage.com. To see Robby Richardson's personal account of his
experience with home hemodialysis, please visit our YouTube
page.
Despite the health benefits that home hemodialysis may
provide to those with chronic kidney disease, this form of therapy
is not for everyone. The reported benefits of home hemodialysis may
not be experienced by all patients. The risks associated with
hemodialysis treatments in any environment include, but are not
limited to, high blood pressure, fluid overload, low blood
pressure, heart-related issues, and vascular access complications.
The medical devices used in hemodialysis therapies may add
additional risks including air entering the bloodstream and blood
loss due to clotting or accidental disconnection of the blood
tubing set. Certain risks are unique to the home. Treatments at
home are done without the presence of medical personnel and on-site
technical support. Patients and their partners must be trained on
what to do and how to get medical or technical help if
needed.
Additional Risks Associated with Nocturnal Home Hemodialysis
Therapy
The NxStage System One may be used at night while
the patient and care partner are sleeping. Certain risks associated
with hemodialysis treatment are increased when performing nocturnal
therapy due to the length of treatment time and because therapy is
performed while the patient and care partner are sleeping. These
risks include, but are not limited to, blood access disconnects and
blood loss during sleep, blood clotting due to slower blood flow or
increased treatment time or both, and delayed response to alarms
when waking from sleep. Ancillary anticoagulant infusion pumps and
fluid leak detection devices may be used to decrease certain risks
for home hemodialysis treatments performed at any time, but NxStage
requires the use of fluid leak detectors to identify leaks from the
vascular access, Cycler and Cartridge when performing nocturnal
therapy with the NxStage System One.
About the NxStage System One
The NxStage System One is
the first and only truly portable hemodialysis system cleared
specifically by the FDA for home hemodialysis and home
nocturnal hemodialysis. Its simplicity and revolutionary size (just
over a foot tall) are intended to allow convenient use in patients'
homes and give patients the freedom to travel with their therapy.
When combined with the NxStage PureFlow SL Dialysis Preparation
System, patients are able to further simplify, using ordinary tap
water to create dialysis fluid on demand. Unlike conventional
hemodialysis systems, the System One requires no special
infrastructure to operate. Under the guidance of their physician,
patients can use the NxStage System One, with their trained
partners, where, how and when it best meets their needs, including
while they are sleeping - at home or on vacation and at a medically
appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical
Inc. (Nasdaq: NXTM) is a medical device company, headquartered
in Lawrence, Massachusetts,
USA, that develops, manufactures and markets innovative
products for the treatment of ESRD and acute kidney failure. For
more information on NxStage and its products, please visit the
Company's website at www.nxstage.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and
Exchange Commission, including the Annual Report on Form 10-K for
the year ended December 31, 2014. NxStage is under no
obligation to (and expressly disclaims any such obligation to)
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Media contact:
Kristen K. Sheppard, Esq.
ksheppard@nxstage
Tel: (978) 332-5923
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-celebrates-second-annual-national-home-hemodialysis-day-300052789.html
SOURCE NxStage Medical Inc.